ArticlePharmaceutics2023

Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization.

Basanth Babu Eedara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.